The IPA demonstrated that important biochemical molecules such as VEGF, ERK1/2, p38 MAPK and PLA2G7, NADPH oxidase, SMAD3 and ODC1 were involved in the biological network associated with berberine against prostate cancer. The gene discussed is ODC1; the disease is prostate carcinoma.